The Latest From SWIFT Medical Solutions
Keeping You Informed
Top 10 Medical Billing Companies in the USA: 2026 Rankings
Rising claim denials are draining revenue faster than ever. According to recent industry data, 73% of healthcare providers report increased denials compared to just 42%
Top Medical Billing Companies in New York (2026 Guide)
New York’s healthcare landscape presents unique challenges, making medical billing more complex than in most states. Between aggressive payer scrutiny, frequent regulatory updates, and one
7 Best Medical Billing Companies In Florida
Florida practices face mounting pressure from all sides. Denial rates keep climbing, A/R cycles stretch longer, payer rules shift without warning, and staffing shortages make
Spravato Insurance Coverage: What Insurance Actually Covers
Many patients and clinics hear “yes, Spravato is covered” only to face denials, prior authorization delays, or unexpected bills. Spravato insurance coverage often feels inconsistent
HIPAA Compliance for Small Businesses: Practical Guidance
Small healthcare businesses face a unique challenge: the same HIPAA obligations as large hospitals, but with limited staff, no compliance officers, and a heavy reliance
Spravato Billing and Coding Guide: 2026 Update
Spravato billing combines medication dispensing, supervised administration, mandatory observation time, and REMS compliance into a single claim. This creates more opportunities for errors than nearly
Spravato Without Insurance: How Much Does It Cost?
If you’re considering Spravato for treatment-resistant depression, the price tag can be startling. Spravato without insurance typically costs between $590 and $885 per treatment session
Hospital Billing vs. Professional Billing: What You Need to Know
Healthcare billing isn’t simple. Many practices struggle because they don’t understand the difference between hospital billing and professional billing. This confusion leads to denied claims,
Top 10 Spravato Billing Services Companies in the USA
Spravato (esketamine nasal spray) is a revolutionary drug for the treatment of resistant depression, approved by the FDA in 2019. However, its administration and payment